(Q36618299)

15 August 2017

Comparison of sequential three-drug regimens as initial therapy for HIV-1 infection (English)

1 reference

15 August 2017

Charles van der Horst

12

object named as

Charles van der Horst

1 reference

15 August 2017

Robert L Murphy

13

0 references

Stefano Vella

object named as

Stefano Vella

16

0 references

Margaret A Fischl

8

object named as

Margaret A Fischl

1 reference

15 August 2017

15

Richard T D'Aquila

1 reference

15 August 2017

Gregory K Robbins

1

1 reference

15 August 2017

Victor De Gruttola

2

1 reference

15 August 2017

Robert W Shafer

3

1 reference

15 August 2017

Laura M Smeaton

4

1 reference

15 August 2017

Sally W Snyder

5

1 reference

15 August 2017

Carla Pettinelli

6

1 reference

15 August 2017

Michael P Dubé

7

1 reference

15 August 2017

Richard B Pollard

9

1 reference

15 August 2017

Robert Delapenha

10

1 reference

15 August 2017

Linda Gedeon

11

1 reference

15 August 2017

Mark I Becker

14

1 reference

15 August 2017

Thomas C Merigan

17

1 reference

15 August 2017

Martin S Hirsch

18

1 reference

15 August 2017

AIDS Clinical Trials Group 384 Team

19

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

The New England Journal of Medicine

15 August 2017

1 reference

15 August 2017

349

1 reference

15 August 2017

24

1 reference

15 August 2017

2293-2303

1 reference

Consequences and determinants of adherence to antiretroviral medication: results from Adult AIDS Clinical Trials Group protocol 370.

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

An introduction to nucleoside and nucleotide analogues.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Treatment with amprenavir alone or amprenavir with zidovudine and lamivudine in adults with human immunodeficiency virus infection. AIDS Clinical Trials Group 347 Study Team.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AAC

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, January 28, 2000 by the Panel on Clinical Practices for Treatment of HIV Infection.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Drug resistance in patients experiencing early virological failure under a triple combination including indinavir

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Factors associated with clinical and virological failure in patients receiving a triple therapy including a protease inhibitor.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4767257

Predictors of Virological Success and Ensuing Failure in HIV-Positive Patients Starting Highly Active Antiretroviral Therapy in Europe

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14668455

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/14668455

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1056/NEJMOA030264

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

14668455

1 reference